News
CHJTF
1.070
NaN%
--
CSPC Launches First-in-Class CAR-T Trial for Refractory Lupus in China
TipRanks · 20h ago
CSPC Pharmaceutical Sets Board Meeting to Approve Interim Results
TipRanks · 1d ago
CSPC Wins U.S. FDA Nod for Clinical Trials of Novel Mpox mRNA Vaccine
TipRanks · 1d ago
CSPC Pharmaceutical Group Secures US$10 Million Milestone From AstraZeneca
TipRanks · 6d ago
CSPC and AstraZeneca Form Biologics Manufacturing Joint Venture in China
TipRanks · 08/05 08:40
CSPC Drug Combo for HER2-Positive Breast Cancer Wins Priority NMPA Review
TipRanks · 08/04 10:07
CSPC Launches Phase Ib/II Trial of Novel PD-1/IL-15 Fusion Therapy for Colorectal Cancer in China
TipRanks · 08/03 11:38
CSPC Launches Phase II Trial of Novel Ovarian Cancer Therapy in China
TipRanks · 07/31 10:15
CSPC Pharmaceutical Uses FX Contracts to Manage USD/RMB Risk
TipRanks · 07/30 10:07
Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
TipRanks · 07/29 00:36
Nomura Sticks to Its Buy Rating for CSPC Pharmaceutical Group (CHJTF)
TipRanks · 07/28 00:27
CSPC’s Novel Antidepressant HA1406 Hits Phase III Trial Target
TipRanks · 07/27 13:08
CSPC Wins Priority Review for Albumin-Bound Sirolimus as Potential New Standard in Rare Tumour Care
TipRanks · 07/27 13:07
CSPC Sees Profit Surge on AstraZeneca Deal and Solid Drug Sales
TipRanks · 07/27 09:37
CSPC Innovation Forecasts First-Half Profit on Biotech R&D Progress
TipRanks · 07/27 09:37
CSPC Wins China Approval for Long-Acting Schizophrenia Injection
TipRanks · 07/24 11:09
CSPC Advances HPV mRNA Vaccine SYS6026 to Phase II Trial in China
TipRanks · 07/22 13:08
CSPC’s HER2-Targeted Breast Cancer Drug NDA Accepted by China’s NMPA
TipRanks · 07/17 09:48
CSPC Advances B7-H3 Antibody-Drug Conjugate into Phase III Ovarian Cancer Trial in China
TipRanks · 07/16 11:54
CSPC Launches Phase II Trial for Albumin-Bound Sirolimus in Rare Vascular Cancer
TipRanks · 07/16 11:53
More
Webull provides a variety of real-time CHJTF stock news. You can receive the latest news about Cspc Pharmaceut through multiple platforms. This information may help you make smarter investment decisions.
About CHJTF
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.